Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
Subscribe To Our Newsletter & Stay Updated
